<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>芯片牛 - 国外药企</title>
    <link>http://www.niugoo.com/discuz/forum.php?mod=forumdisplay&amp;fid=83</link>
    <description>Latest 20 threads of 国外药企</description>
    <copyright>Copyright(C) 芯片牛</copyright>
    <generator>Discuz! Board by Comsenz Inc.</generator>
    <lastBuildDate>Tue, 28 Apr 2026 02:08:47 +0000</lastBuildDate>
    <ttl>60</ttl>
    <image>
      <url>http://www.niugoo.com/discuz/static/image/common/logo_88_31.gif</url>
      <title>芯片牛</title>
      <link>http://www.niugoo.com/discuz/</link>
    </image>
    <item>
      <title>诺和诺德：走下神坛的一年</title>
      <link>http://www.niugoo.com/discuz/forum.php?mod=viewthread&amp;tid=1907</link>
      <description><![CDATA[https://www.huxiu.com/article/4814451.html]]></description>
      <category>国外药企</category>
      <author>老牛</author>
      <pubDate>Sun, 07 Dec 2025 06:13:50 +0000</pubDate>
    </item>
    <item>
      <title>川普大药房：减肥药打2折，让美国人减重5600万公斤</title>
      <link>http://www.niugoo.com/discuz/forum.php?mod=viewthread&amp;tid=1876</link>
      <description><![CDATA[https://www.huxiu.com/article/4804419.html]]></description>
      <category>国外药企</category>
      <author>老牛</author>
      <pubDate>Mon, 17 Nov 2025 04:21:16 +0000</pubDate>
    </item>
    <item>
      <title>“天价”救命药赫赛汀的替代之战</title>
      <link>http://www.niugoo.com/discuz/forum.php?mod=viewthread&amp;tid=386</link>
      <description><![CDATA[http://www.cb.com.cn/index/show/bzyc/cv/cv13482391649

赫赛汀，又称注射用曲妥珠单抗，是罗氏集团在全球最畅销的抗肿瘤产品之一。1998年，赫赛汀首次被美国FDA批准治疗HER2阳性乳腺癌，此后又获批用于HER2阳性转移性胃癌。目前其已经成为HER2阳性乳腺癌全程治疗的金 ...]]></description>
      <category>国外药企</category>
      <author>老牛</author>
      <pubDate>Sat, 05 Dec 2020 10:13:43 +0000</pubDate>
    </item>
    <item>
      <title>救命呼吸机：全球第一医疗器械公司美敦力</title>
      <link>http://www.niugoo.com/discuz/forum.php?mod=viewthread&amp;tid=160</link>
      <description><![CDATA[https://weibo.com/ttarticle/p/show?id=2309404494746578977100]]></description>
      <category>国外药企</category>
      <author>老牛</author>
      <pubDate>Fri, 17 Apr 2020 11:29:43 +0000</pubDate>
    </item>
    <item>
      <title>抗疫概念股Moderna盘前大涨21%，此前两日飙涨近57%</title>
      <link>http://www.niugoo.com/discuz/forum.php?mod=viewthread&amp;tid=111</link>
      <description><![CDATA[https://news.futunn.com/market/114285?src=3]]></description>
      <category>国外药企</category>
      <author>老牛</author>
      <pubDate>Fri, 28 Feb 2020 13:04:05 +0000</pubDate>
    </item>
    <item>
      <title>2019年全球表现最好的新药：7个中国已上市</title>
      <link>http://www.niugoo.com/discuz/forum.php?mod=viewthread&amp;tid=96</link>
      <description><![CDATA[https://med.sina.com/article_detail_103_2_77952.html]]></description>
      <category>国外药企</category>
      <author>老牛</author>
      <pubDate>Mon, 24 Feb 2020 13:29:45 +0000</pubDate>
    </item>
    <item>
      <title>在治疗乳腺癌上，HER2抑制剂有什么突出表现？</title>
      <link>http://www.niugoo.com/discuz/forum.php?mod=viewthread&amp;tid=95</link>
      <description><![CDATA[https://weibo.com/ttarticle/p/show?id=2309404475544463868185]]></description>
      <category>国外药企</category>
      <author>老牛</author>
      <pubDate>Mon, 24 Feb 2020 13:25:13 +0000</pubDate>
    </item>
    <item>
      <title>礼来2019财报：中国Q4狂增44% 达伯舒功不可没</title>
      <link>http://www.niugoo.com/discuz/forum.php?mod=viewthread&amp;tid=77</link>
      <description><![CDATA[GBI消息，近日，美国制药巨头礼来公司发布了其2019年业绩，全年收入223.2亿美元，同比增长4％。公司第四季度增速明显，销售额达到61.1亿美元，同比增长8％。全年净利润为46.4亿美元，增长47％。礼来公司CEO David A. Ricks表示，公司目前正处于令人兴奋的快速增长的早期 ...]]></description>
      <category>国外药企</category>
      <author>老牛</author>
      <pubDate>Thu, 13 Feb 2020 08:21:26 +0000</pubDate>
    </item>
    <item>
      <title>2020年即将上市销售的重磅新药Top10</title>
      <link>http://www.niugoo.com/discuz/forum.php?mod=viewthread&amp;tid=66</link>
      <description><![CDATA[https://med.sina.com/article_detail_103_2_77329.html]]></description>
      <category>国外药企</category>
      <author>老牛</author>
      <pubDate>Sun, 09 Feb 2020 08:11:55 +0000</pubDate>
    </item>
  </channel>
</rss>